Category

• Pipeline1
• Research1

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• AMD2
• Geographic Atrophy2
• FDA1
• Clinical Trials1
• Gene Therapy1
• Retina1
• Wet Amd1

• Organizations: Complement Therapeutics✕

Clear all

Pipeline

Complement Therapeutics' GA gene therapy IND receives FDA clearance

Clearance gives green light to begin Q1 2026 patient enrollment for the Opti-GAIN study evaluating CTx001 as a one-time, durable treatment.

Research

First patient enrolled in study on GA secondary to AMD

The non-interventional i-GAIN study will track disease progression over 12 months.